ArticleJournal for immunotherapy of cancer2021

Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity.

Kevin Jan Legscha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.